Greenwich Lifesciences Inc (GLSI) — Financial Flexibility Index
Greenwich Lifesciences Inc (GLSI) has a Financial Flexibility Index of -1.65x as of September 2025. Free cash flow of $-2.67 Million (operating CF $-2.67 Million minus capex $7.00) represents -2% of total liabilities ($1.62 Million). Also explore Greenwich Lifesciences Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Greenwich Lifesciences Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Greenwich Lifesciences Inc across 8 annual periods. See Greenwich Lifesciences Inc (GLSI) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Greenwich Lifesciences Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Greenwich Lifesciences Inc. For the full company profile including market capitalisation, see GLSI market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.66x | $-7.27 Million | $-7.27 Million | $1.56 Million | ▲ +78.8% |
| 2023 | -22.01x | $-6.48 Million | $-6.48 Million | $294.41K | ▲ +6.7% |
| 2022 | -23.58x | $-6.20 Million | $-6.20 Million | $262.90K | ▼ -111.7% |
| 2021 | -11.14x | $-4.29 Million | $-4.29 Million | $385.17K | ▼ -910.3% |
| 2020 | -1.10x | $-1.15 Million | $-1.15 Million | $1.05 Million | ▼ -417.8% |
| 2019 | -0.21x | $-293.27K | $-293.27K | $1.38 Million | ▼ -1795.0% |
| 2018 | -0.01x | $-114.95K | $-114.95K | $10.23 Million | ▲ +20.4% |
| 2017 | -0.01x | $-120.85K | $-120.85K | $8.56 Million | — |